Potential impact of optimal implementation of evidence-based heart failure therapies on mortality

American Heart Journal

Volumn 161, Issue 6, 2011, Pages

  Fonarow, Gregg C ^a   Yancy, Clyde W ^b   Hernandez, Adrian F ^c   Peterson, Eric D ^c   Spertus, John A ^d   Heidenreich, Paul A ^e  

^a UCLA MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^e VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BISOPROLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; ISOSORBIDE DINITRATE; METOPROLOL SUCCINATE;

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ASSESSMENT; DEFIBRILLATOR; EVIDENCE BASED PRACTICE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; TREATMENT INDICATION;

EID: 79958115013     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.01.027     Document Type: Article

References (49)

1. D. Lloyd-Jones, R. Adams, and T.M. Brown Heart disease and stroke statistics-2010 update: a report from the American Heart Association Circulation 121 2010 e46 e215
2. S.A. Hunt, W.T. Abraham, and M.H. Chin ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult Circulation 112 2005 e154 e235
3. S.A. Hunt, W.T. Abraham, and M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults Circulation 119 2009 e391 e479
4. The SOLVD Investigators Effect of enalapril in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
5. R. Garg, and S. Yusuf Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials JAMA 273 1995 1450 1456
6. M.D. Flather, S. Yusuf, and L. Køber Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group Lancet 355 2000 1575 1581 (Pubitemid 30240501)
7. MERIT-HF Investigators Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
8. M. Packer, A.J.S. Coats, and M.B. Fowler Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658 (Pubitemid 32479962)
9. P.A. Heidenreich, T.T. Lee, and B.M. Massie Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials J Am Coll Cardiol 30 1997 27 34 (Pubitemid 27357123)
10. J.M. Brophy, L. Joseph, and J.L. Rouleau Beta-blockers in congestive heart failure: a Bayesian meta-analysis Ann Intern Med 134 2001 550 560 (Pubitemid 32245316)
11. B. Pitt, F. Zannad, and W.J. Remme The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717 (Pubitemid 29407370)
12. B. Pitt, W. Remme, and F. Zannad Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321 (Pubitemid 36384098)
13. J.A. Ezekowitz, and F.A. McAlister Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials Eur Heart J 30 2009 469 477
14. A.L. Taylor, S. Ziesche, and C. Yancy Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N Engl J Med 351 2004 2049 2057
15. A.J. Moss, W. Zareba, and W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883 (Pubitemid 34984635)
16. G.H. Bardy, K.L. Lee, and D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237 (Pubitemid 40110811)
17. A. Desai, J. Fang, and W. Maisel Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials JAMA 292 2004 2874 2879 (Pubitemid 39628235)
18. J.A. Ezekowitz, B.H. Rowe, and D.M. Dryden Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction Ann Intern Med 147 2007 251 262 (Pubitemid 351664582)
19. M.R. Bristow, L.A. Saxon, and J. Boehmer Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
20. J.G. Cleland, J.C. Daubert, and E. Erdmann The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549 (Pubitemid 40517094)
21. F.A. McAlister, J. Ezekowitz, and N. Hooton Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review JAMA 297 2007 2502 2514 (Pubitemid 46953404)
22. M. Rivero-Ayerza, D.A. Theuns, and H.M. Garcia-Garcia Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials Eur Heart J 27 2006 2682 2688 (Pubitemid 44729869)
23. G.C. Fonarow, C.W. Yancy, and J.T. Heywood Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry Arch Intern Med 165 2005 1469 1477 (Pubitemid 41058026)
24. D.S. Lee, J.V. Tu, and D.N. Juurlink Risk-treatment mismatch in the pharmacotherapy of heart failure JAMA 294 2005 1240 1247 (Pubitemid 41352112)
25. G.C. Fonarow, C.W. Yancy, and N.M. Albert Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF Circ Heart Fail 1 2008 98 106
26. N.M. Albert, C.W. Yancy, and L. Liang Use of aldosterone antagonists in heart failure JAMA 302 2009 1658 1665
27. J.P. Piccini, A.F. Hernandez, and D. Dai Use of cardiac resynchronization therapy in patients hospitalized with heart failure Circulation 118 2008 926 933
28. G.C. Fonarow, W.G. Stough, and W.T. Abraham Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry J Am Coll Cardiol 50 2007 768 777 (Pubitemid 47243795)
29. G.C. Fonarow, N.M. Albert, and A.B. Curtis Improving evidence-based care for heart failure in outpatient cardiology practices. Primary results of the Registry to Improve the Use of Evidence-based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) Circulation 122 2010 585 596
30. P.S. Chan, W.J. Oetgen, and D. Buchanan Cardiac performance measure compliance in outpatients: the American College of Cardiology and National Cardiovascular Data Registry's PINNACLE (Practice Innovation And Clinical Excellence) program J Am Coll Cardiol 56 2010 8 14
31. K.P. Alexander, E.D. Peterson, and C.B. Granger Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trial J Am Coll Cardiol 32 1998 2023 2030 (Pubitemid 29010471)
32. D.P. Chew, L.T. Huynh, and D. Liew Potential survival gains in the treatment of myocardial infarction Heart 95 2009 1844 1850
33. F.A. Masoudi, S.S. Rathore, and Y. Wang National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction Circulation 110 2004 724 731 (Pubitemid 39056273)
34. A.F. Hernandez, B.G. Hammill, and C.M. O'Connor Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF registry J Am Coll Cardiol 53 2009 184 192
35. A.F. Hernandez, G.C. Fonarow, and B.G. Hammill Clinical effectiveness of implantable cardioverter-defibrillators among Medicare beneficiaries with heart failure Circ Heart Fail 3 2010 7 13
36. P.S. Chan, B.K. Nallamothu, and J.A. Spertus Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention Circ Cardiovasc Qual Outcomes 2 2009 16 24
37. P.W. Groeneveld, S.A. Farmer, and J.J. Suh Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly Heart Rhythm 5 2008 646 653
38. A.F. Hernandez, B.G. Hammill, and E.D. Peterson Relationships between emerging measures of heart failure processes of care and clinical outcomes Am Heart J 159 2010 406 413
39. K.B. Shah, K. Rao, and R. Sawyer The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure J Am Coll Cardiol 46 2005 845 849 (Pubitemid 41224809)
40. E.J. Stanek, M.B. Oates, and W.F. McGhan Preferences for treatment outcomes in patients with heart failure: symptoms versus survival J Card Fail 6 2000 225 232
41. H. Glick, J. Cook, and B. Kinosian Costs and effects of enalapril therapy in patients with symptomatic heart failure: an economic analysis of the Studies of Left Ventricular Dysfunction (SOLVD) Treatment Trial J Card Fail 1 1995 371 380
42. D. Gregory, J.E. Udelson, and M.A. Konstam Economic impact of beta blockade in heart failure Am J Med 110 2001 74S 80S
43. H.A. Glick, S.M. Orzol, and J.F. Tooley Economic evaluation of the randomized aldactone evaluation study (RALES): treatment of patients with severe heart failure Cardiovasc Drugs Ther 16 2002 53 59 (Pubitemid 34606612)
44. D.C. Angus, W.T. Linde-Zwirble, and S.W. Tam Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure Circulation 112 2005 3745 3753 (Pubitemid 43739515)
45. G.D. Sanders, M.A. Hlatky, and D.K. Owens Cost-effectiveness of implantable cardioverter-defibrillators N Engl J Med 353 2005 1471 1480 (Pubitemid 41400921)
46. A.S. Tang, G.A. Wells, and M. Talajic Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med 363 2010 2385 2395
47. F. Zannad, J.J. McMurray, and H. Krum Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21
48. The Institute of Medicine Crossing the quality chasm: a new health system for the 21st century 2001 National Academy Press Washington, DC
49. F.A. McAlister, S. Stewart, and S. Ferrua Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials J Am Coll Cardiol 44 2004 810 819 (Pubitemid 39099578)